Would-Be Coronavirus Drugs Are Cheap To Make
With a vaccine for the novel coronavirus still likely a year or more away, the first weapon against the virus could be one of the drugs now in clinical trials with COVID-19 patients.
With a vaccine for the novel coronavirus still likely a year or more away, the first weapon against the virus could be one of the drugs now in clinical trials with COVID-19 patients.
Controversy surrounds the race to find a medical solution to COVID-19.
Mass vaccination campaigns against a host of diseases are already grinding to a halt in many countries.
The head of the World Health Organization today gave an impassioned but indirect rejoinder to recent comments from U.S. President Donald Trump criticizing WHO’s handling of the coronavirus pandemic.
Social scientists are examining how the coronavirus pandemic is affecting everything from people’s behavior to the economy.
Many people will likely deal with lingering effects of the coronavirus—and of the emergency treatments that allowed them to survive it.
Leaders at the European Research Council have hit back at its former president, who caused an uproar yesterday by resigning barely 3 months into the job.
As the COVID-19 pandemic sweeps into South Africa, the country's experience with handling tuberculosis (TB) and HIV could give it an advantage. But those infections could also worsen the pandemic’s impact.
A trial was designed in which health care workers in Asia, Africa, and Europe will receive two old drugs used against malaria.
The emergency authorization of malaria drugs for use towards fighting coronavirus has received backlash from former FDA executives.
To understand the true extent of the new coronavirus, researchers across the United States are examining donated blood.
Many websites are tracking the disease and death caused by the coronavirus. But one of the earliest, an online dashboard run by Johns Hopkins University, has become the go-to place for the latest data on coronavirus disease 2019 (COVID-19).